Spironolactone improves angiotensin-induced vascular changes and oxidative stress

被引:336
作者
Virdis, A [1 ]
Neves, MF [1 ]
Amiri, F [1 ]
Viel, E [1 ]
Touyz, RM [1 ]
Schiffrin, EL [1 ]
机构
[1] Univ Montreal, Multidisciplinary Res Grp Hypertens, Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada
关键词
aldosterone; angiotensin II; endothelium; hypertension; arterial; oxidative stress; remodeling; rats;
D O I
10.1161/01.HYP.0000034738.79310.06
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Angiotensin II plays an important role in vascular remodeling. We investigated the role of aldosterone, which is stimulated by angiotensin II, as a mediator of angiotensin II-induced vascular structural and functional alterations. Sprague-Dawley rats (n=8 to 12/group) received angiotensin II (120 ng/kg per minute, subcutaneously) for 14 days spironolactone or hydralazine (25 mg/kg per day). An additional group received aldosterone (750 ng/h, subcutaneously) +/- spironolactone. Systolic blood pressure was increased by angiotensin II (P<0.001) and reduced by spironolactone and hydralazine (P<0.001). Aldosterone-induced increase of blood pressure was reduced by spironolactone (P<0.05). In mesenteric small arteries studied on a pressurized myograph, media/lumen ratio was increased (P<0.001) and acetylcholine-mediated relaxation was impaired in angiotensin II-infused rats (P<0.001); both were partially improved by spironolactone (P<0.05) but not by hydralazine. Aldosterone-induced increase of media/lumen ratio (P<0.001) and impaired response to acetylcholine (P<0.001) were normalized by spironolactone. Response to sodium nitroprusside was similar in all groups. Aortic NADPH oxidase activity was increased (P<0.01) by angiotensin II and reduced by spironolactone and hydralazine. Aldosterone also increased (P<0.05) activation of NADPH oxidase, an effect abolished by spironolactone. Plasma thiobarbituric acid-reactive substances (a marker of oxidative stress), higher in angiotensin II and aldosterone rats (P<0.001), were normalized by spironolactone. In conclusion, spironolactone, which inhibited aldosterone actions, partially corrected structural and functional angiotensin II-induced abnormalities. These effects were associated with reduced vascular NADPH oxidase activity and decreased plasma markers of oxidative stress. Our findings suggest that aldosterone may mediate some of angiotensin II-induced vascular effects in hypertension, in part via increased oxidative stress.
引用
收藏
页码:504 / 510
页数:7
相关论文
共 41 条
  • [21] REGULATION OF ALDOSTERONE SECRETION
    QUINN, SJ
    WILLIAMS, GH
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, 1988, 50 : 409 - 426
  • [22] Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation - Contribution to alterations of vasomotor tone
    Rajagopalan, S
    Kurz, S
    Munzel, T
    Tarpey, M
    Freeman, BA
    Griendling, KK
    Harrison, DG
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (08) : 1916 - 1923
  • [23] Vascular hypertrophy and remodeling in secondary hypertension
    Rizzoni, D
    Porteri, E
    Castellano, M
    Bettoni, G
    Muiesan, ML
    Muiesan, P
    Giulini, SM
    AgabitiRosei, E
    [J]. HYPERTENSION, 1996, 28 (05) : 785 - 790
  • [24] Mineralocorticoid blockade reduces vascular injury in stroke prone hypertensive rats
    Rocha, R
    Chander, PN
    Khanna, K
    Zuckerman, A
    Stier, CT
    [J]. HYPERTENSION, 1998, 31 (01) : 451 - 458
  • [25] SCHIFFRIN EL, 1992, HYPERTENSION, V19, P1
  • [26] EFFECT OF ALDOSTERONE ON VASCULAR ANGIOTENSIN-II RECEPTORS IN THE RAT
    SCHIFFRIN, EL
    FRANKS, DJ
    GUTKOWSKA, J
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1985, 63 (12) : 1522 - 1527
  • [27] Schiffrin EL, 2000, CIRCULATION, V101, P1653
  • [28] VASCULAR ANGIOTENSIN-II RECEPTORS IN RENAL AND DOCA-SALT HYPERTENSIVE RATS
    SCHIFFRIN, EL
    THOME, FS
    GENEST, J
    [J]. HYPERTENSION, 1983, 5 (06) : V16 - V21
  • [29] Vascular smooth muscle growth and extracellular matrix deposition: is there a role for the sympathetic nervous system?
    Schiffrin, EL
    [J]. JOURNAL OF HYPERTENSION, 2002, 20 (02) : 179 - 181
  • [30] TBARS and cardiovascular disease in a population-based sample
    Schisterman, EF
    Faraggi, D
    Browne, R
    Freudenheim, J
    Dorn, J
    Muti, P
    Armstrong, D
    Reiser, B
    Trevisan, M
    [J]. JOURNAL OF CARDIOVASCULAR RISK, 2001, 8 (04): : 219 - 225